Add to ORKGThe management of idiopathic intracranial hypertension (IIH) is focused on reducing ICP to try to both preserve visual function, as well as reduce chronic headaches. There is sparse evidence to support the use of some of the drugs commonly used to manage IIH, therefore we propose to evaluate the efficacy of acetazolamide, topiramate, furosemide, amiloride and octreotide at lowering ICP in healthy rats
Treatment of raised intracranial pressure is both medical and surgical. It is aimed mainly at loweri...
Idiopathic intracranial hypertension (IIH) is a disease of unknown etiology that occurs primarily in...
Idiopathic intracranial hypertension (IIH) is an uncommon disorder characterized by increased intrac...
The management of idiopathic intracranial hypertension (IIH) is focused on reducing ICP to try to bo...
Limited data exists to guide treatment of idiopathic intracranial hypertension (IIH). We examined th...
BACKGROUND The management of idiopathic intracranial hypertension focuses on reducing intracrania...
WOS: 000249990000008PubMed ID: 17922725Objectives - To assess the efficacy of topiramate in the trea...
Topiramate is approved for the treatment of epilepsy and migraine prophylaxis. It also actS as a car...
The NORDIC IIH treatment trial established new standards regarding the use and dosing of acetazolami...
Idiopathic intracranial hypertension (IIH) is characterized by elevation of intracranial pressure (I...
The cause of Idiopathic intracranial hypertension (IIH) remains unknown and no consensus exists on h...
Background: Limited clinical data exists to guide treatment of idiopathic intracranial hypertension ...
INTRODUCTION: Idiopathic intracranial hypertension is a neurological condition characterized by a ra...
There is increasing evidence and appreciation of idiopathic intracranial hypertension (IIH) in medic...
Treatment of idiopathic intracranial hypertension (IIH) is based on anecdotal uncontrolled data as t...
Treatment of raised intracranial pressure is both medical and surgical. It is aimed mainly at loweri...
Idiopathic intracranial hypertension (IIH) is a disease of unknown etiology that occurs primarily in...
Idiopathic intracranial hypertension (IIH) is an uncommon disorder characterized by increased intrac...
The management of idiopathic intracranial hypertension (IIH) is focused on reducing ICP to try to bo...
Limited data exists to guide treatment of idiopathic intracranial hypertension (IIH). We examined th...
BACKGROUND The management of idiopathic intracranial hypertension focuses on reducing intracrania...
WOS: 000249990000008PubMed ID: 17922725Objectives - To assess the efficacy of topiramate in the trea...
Topiramate is approved for the treatment of epilepsy and migraine prophylaxis. It also actS as a car...
The NORDIC IIH treatment trial established new standards regarding the use and dosing of acetazolami...
Idiopathic intracranial hypertension (IIH) is characterized by elevation of intracranial pressure (I...
The cause of Idiopathic intracranial hypertension (IIH) remains unknown and no consensus exists on h...
Background: Limited clinical data exists to guide treatment of idiopathic intracranial hypertension ...
INTRODUCTION: Idiopathic intracranial hypertension is a neurological condition characterized by a ra...
There is increasing evidence and appreciation of idiopathic intracranial hypertension (IIH) in medic...
Treatment of idiopathic intracranial hypertension (IIH) is based on anecdotal uncontrolled data as t...
Treatment of raised intracranial pressure is both medical and surgical. It is aimed mainly at loweri...
Idiopathic intracranial hypertension (IIH) is a disease of unknown etiology that occurs primarily in...
Idiopathic intracranial hypertension (IIH) is an uncommon disorder characterized by increased intrac...